DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Global Dementia and Alzheimer’s Disease Treatment Market, By Drug Class
     • Global Dementia and Alzheimer’s Disease Treatment Market, By Route of Administration
     • Global Dementia and Alzheimer’s Disease Treatment Market, By Distribution Channel
     • Global Dementia and Alzheimer’s Disease Treatment Market, By Gender
     • Global Dementia and Alzheimer’s Disease Treatment Market, By Patient Demographics
     • Global Dementia and Alzheimer’s Disease Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
   • Driver
   • Restraint
   • Opportunity
   • Impact Analysis
   • Key Developments
   • Regulatory Scenario
   • Product Launches/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger and Acquisition Scenario
   • Industry Trends

4. Global Dementia and Alzheimer’s Disease Treatment Market, By Drug Class, 2021 - 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Cholinesterase Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
       • Donepezil
       • Rivastigmine
       • Galantamine
   • NMDA Receptor Antagonists
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
       • Memantine
       • Amantadine
   • Antidepressants
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
       • Selective Serotonin Reuptake Inhibitors (SSRIs)
       • Tricyclic Antidepressants (TCAs)
   • Antipsychotics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
       • Atypical Antipsychotics
       • Typical Antipsychotics
   • Disease-Modifying Therapies (DMTs)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
       • Anti-Amyloid Monoclonal Antibodies
       • Protein Inhibitors
       • Anti-inflammatory Agents
   • Combination Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
       • Donepezil + Memantine (Namzaric)
       • Rivastigmine + Memantine
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Dementia and Alzheimer’s Disease Treatment Market, By Route of Administration, 2021 - 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Oral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Parenteral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Transdermal
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Dementia and Alzheimer’s Disease Treatment Market, By Distribution Channel, 2021 - 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Dementia and Alzheimer’s Disease Treatment Market, By Gender, 2021 - 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Male
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Female
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Dementia and Alzheimer’s Disease Treatment Market, By Patient Demographics, 2021 - 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Adults
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Geriatrics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
   • Pediatrics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Dementia and Alzheimer’s Disease Treatment Market, By Region, 2021 - 2033, Value (USD Bn)

   • Introduction
     • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
     • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
       • Brazil
       • Argentina
       • Mexico
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
       • Germany
       • U.K.
       • Spain
       • France
       • Italy
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
       • GCC Countries
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
     • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
       
       • South Africa
       • North Africa
       • Central Africa

10. Competitive Landscape

    • Biogen Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Roche Holding AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Amgen Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi S.A.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AstraZeneca PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Lundbeck A/S
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Otsuka Pharmaceutical Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

11. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map

12. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘Dementia and Alzheimer’s Disease Treatment Market' - Global forecast to 2033